Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

Similar articles for PubMed (Select 22452851)

1.

Production of recombinant nonstructural 1 protein in Escherichia coli for early detection of Japanese encephalitis virus infection.

Tripathi NK, Kumar JS, Biswal KC, Rao PV.

Microb Biotechnol. 2012 Sep;5(5):599-606. doi: 10.1111/j.1751-7915.2012.00344.x. Epub 2012 Mar 27.

2.

Production of recombinant Chikungunya virus envelope 2 protein in Escherichia coli.

Tripathi NK, Priya R, Shrivastava A.

Appl Microbiol Biotechnol. 2014 Mar;98(6):2461-71. doi: 10.1007/s00253-013-5426-4. Epub 2013 Dec 13.

PMID:
24337252
3.

Development of a simple fed-batch process for the high-yield production of recombinant Japanese encephalitis virus protein.

Tripathi NK, Shukla J, Biswal KC, Lakshmana Rao PV.

Appl Microbiol Biotechnol. 2010 May;86(6):1795-803. doi: 10.1007/s00253-010-2488-4. Epub 2010 Feb 23.

PMID:
20177885
4.

High-level expression of recombinant dengue viral NS-1 protein and its potential use as a diagnostic antigen.

Huang JL, Huang JH, Shyu RH, Teng CW, Lin YL, Kuo MD, Yao CW, Shaio MF.

J Med Virol. 2001 Nov;65(3):553-60.

PMID:
11596093
5.

Development of a pilot-scale production process and characterization of a recombinant Japanese encephalitis virus envelope domain III protein expressed in Escherichia coli.

Tripathi NK, Shrivastava A, Biswal KC, Rao PV.

Appl Microbiol Biotechnol. 2012 Sep;95(5):1179-89. doi: 10.1007/s00253-012-4100-6. Epub 2012 May 6.

PMID:
22562165
6.

Recombinant dengue virus type 3 envelope domain III protein from Escherichia coli.

Tripathi NK, Shrivastava A, Biswal KC, Rao PV.

Biotechnol J. 2011 May;6(5):604-8. doi: 10.1002/biot.201000399. Epub 2011 Feb 9.

PMID:
21538895
8.

Japanese encephalitis virus structural and nonstructural proteins expressed in Escherichia coli induce protective immunity in mice.

Tafuku S, Miyata T, Tadano M, Mitsumata R, Kawakami H, Harakuni T, Sewaki T, Arakawa T.

Microbes Infect. 2012 Feb;14(2):169-76. doi: 10.1016/j.micinf.2011.09.004. Epub 2011 Oct 4.

PMID:
22001496
9.

Production and characterization of recombinant dengue virus type 4 envelope domain III protein.

Tripathi NK, Babu JP, Shrivastva A, Parida M, Jana AM, Rao PV.

J Biotechnol. 2008 Apr 30;134(3-4):278-86. doi: 10.1016/j.jbiotec.2008.02.001. Epub 2008 Feb 13.

PMID:
18342971
10.

Production and single-step purification of Brugia malayi abundant larval transcript (ALT-2) using hydrophobic interaction chromatography.

Bhuvanesh S, Arunkumar C, Kaliraj P, Ramalingam S.

J Ind Microbiol Biotechnol. 2010 Oct;37(10):1053-9. doi: 10.1007/s10295-010-0753-2. Epub 2010 Jul 1.

PMID:
20593300
11.

Super induction of dengue virus NS1 protein in E. coli.

Das D, Mongkolaungkoon S, Suresh MR.

Protein Expr Purif. 2009 Jul;66(1):66-72. doi: 10.1016/j.pep.2009.02.003. Epub 2009 Feb 14.

PMID:
19232392
12.

Immunogenicity of baculovirus expressed recombinant proteins of Japanese encephalitis virus in mice.

Yang DK, Kweon CH, Kim BH, Lim SI, Kwon JH, Kim SH, Song JY, Han HR.

J Vet Sci. 2005 Jun;6(2):125-33.

13.

Fed batch fermentation and purification strategy for high yield production of Brucella melitensis recombinant Omp 28 kDa protein and its application in disease diagnosis.

Karothia BS, Athmaram TN, D T, Ashu K, Tiwari S, Singh AK, Sathyaseelan K, Gopalan N.

Protein Pept Lett. 2013 Jul 1;20(7):731-40.

PMID:
23167982
14.

Production of recombinant bacteriocin divercin V41 by high cell density Escherichia coli batch and fed-batch cultures.

Yildirim S, Konrad D, Calvez S, Drider D, Prévost H, Lacroix C.

Appl Microbiol Biotechnol. 2007 Dec;77(3):525-31. Epub 2007 Sep 19.

PMID:
17882416
15.
16.

Development of a simple fed-batch process for the high-yield production of recombinant shiga toxin B-chain protein.

Sharma K, Gupta P, Kumar Singh A, Gopalan N, Kumar Dhaked R, Lakshmana Rao PV.

Protein Pept Lett. 2012 Feb;19(2):228-37.

PMID:
21838697
17.

Cloning and expression of domain III of the envelope gene of Japanese encephalitis virus: evaluation for early clinical diagnosis by IgM ELISA.

Shukla J, Bhargava R, Dash PK, Parida M, Tripathi N, Rao PV.

J Virol Methods. 2009 Jun;158(1-2):165-70. doi: 10.1016/j.jviromet.2009.02.018. Epub 2009 Feb 27.

PMID:
19428586
18.

High cell density cultivation and recombinant protein production with Escherichia coli in a rocking-motion-type bioreactor.

Glazyrina J, Materne EM, Dreher T, Storm D, Junne S, Adams T, Greller G, Neubauer P.

Microb Cell Fact. 2010 May 30;9:42. doi: 10.1186/1475-2859-9-42.

19.

Optimization of Dengue-3 recombinant NS1 protein expression in E. coli and in vitro refolding for diagnostic applications.

Athmaram TN, Saraswat S, Misra P, Shrivastava S, Singh AK, Verma SK, Gopalan N, Behara PK, Rao PV.

Virus Genes. 2013 Apr;46(2):219-30. doi: 10.1007/s11262-012-0851-5. Epub 2012 Nov 28.

PMID:
23188193
20.

Circulating human antibodies against dengue NS1 protein: potential of recombinant D2V-NS1 proteins in diagnostic tests.

Lemes EM, Miagostovicsh MP, Alves AM, Costa SM, Fillipis AM, Armoa GR, Araujo MA.

J Clin Virol. 2005 Apr;32(4):305-12.

PMID:
15780810
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk